At the same time, management has emphasized that most revenue still comes from non GLP-1 products and has laid out 2026 revenue guidance of US$2.7b to US$2.9b, alongside continued investment in new specialties and international expansion
Sheena Alli (Sahibdeen)s Post The GLP-1 conversation is starting to change
While safety and tolerability have traditionally been used as go/no-go criteria in early-phase clinical trials (Stallard et al., 2001), a growing repertoire of biomarkers that can be used to evaluate short-term intervention effects, such as target engagement, pharmacodynamics, and effects predictive of clinical benefit, may additionally be used to inform go/no-go decisions and over time begin to reduce the number of negative phase 3 clinical trials (Boxer and Sperling, 2023
Drift Peptides GHK-CU $149 Drift Peptides includes GHK-CU, a copper-binding peptide that plays a vital role in tissue repair, boosting collagen and elastin, and reducing signs of aging
Glutathione therapy can help detoxify your body, brighten your skin, and strengthen your immune system